It's not the easiest table to read but revenue is actually up 2% despite 4% less generation - reflecting high prices. I'll guess these prices are up even further so far this quarter. Looking to buy more.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025